Elan

124 results

Healthcare services company UDG said the Covid-19 pandemic hit trading in the third quarter, but the group reinstated its interim dividend and financi(...)

Perrigo claims it had a legitimate expectation that the sale of rights to multiple sclerosis drug Tysabri to Biogen would be treated as trading income not a capital gain

Drug company Perrigo is not a “sacrificial victim” of the Revenue Commissioners arising from a €1.6 billion tax assessment, and it has not been single(...)

Perrigo bought Elan in 2013 by way of corporate inversion. Photograph: Adam Bird/Bloomberg via Getty Images

The Revenue Commissioners has disputed claims it had no entitlement to raise a €1.64 billion tax assessment against drug company Perrigo. That amend(...)

Perrigo claims Revenue had no right to raise the assessment and Perrigo had a legitimate expectation it would not do so. Photograph: Bloomberg via Getty

A €1.64 billion tax assessment raised on drug company Perrigo by the Revenue Commissioners involved a “very high level of unfairness” and came as a “s(...)

The taxation dispute stems from Perrigo’s purchase of Irish company  Elan in 2013 by way of corporate inversion. Photograph: Bloomberg

A legal challenge by US drug company Perrigo aimed at quashing a €1.64 billion tax assessment raised on it by the Revenue Commissioners will formally (...)

Revenue says Perrigo owes the €1.64 billion because of its purchase of Irish pharma group Elan in 2013 and the sale by Elan eight months previously of its MS drug Tysabri to Biogen. Photograph: Adam Bird/Bloomberg via Getty Images

The Revenue Commissioners go to court this week to defend on of the most contentious tax bills levied on a company in Ireland. US drug company Perri(...)

A Perrigo facility in Allegan, Michigan. Photograph: Adam Bird/Bloomberg via Getty Images

Drug company Perrigo has a better than even chance of seeing off a demand from Irish Revenue for €1.64 billion in back taxes, according to a US indust(...)

A major push towards legalisation here may come from US and Canadian cannabis corporations who view Ireland as a jump-off point into the EU market. Photograph:  Rungroj Yongrit/EPA

It is inevitable that cannabis will be legalised in Ireland in the coming years. It may take five years or even longer for the prohibition to be fully(...)

Perrigo bought Elan eight months after the company had sold the Tysabri intellectual property.

Over-the-counter drug specialist Perrigo has once again hit out at the Revenue decision to pursue it for €1.64 billion in back taxes. Speaking to ana(...)

 A Perrigo  facility in  Michigan, US.  Perrigo bought Elan eight months after the Tysabri deal in a  so-called “inversion” deal. Photograph: Getty Images

North American stockbroking analysts have predicted that drugs giant Perrigo has an 80 per cent chance of a “favourable outcome” to the company’s €1.6(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »